![]() |
市场调查报告书
商品编码
1882990
自动化内视镜清洗消毒机 (AER) 市场规模、占有率、成长及全球产业分析:按类型、应用和地区划分的洞察与预测 (2024-2032)Automated Endoscope Reprocessors (AER) Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032 |
||||||
随着全球医疗系统日益重视更严格的感染控制、标准化的消毒流程以及微创诊断技术的广泛应用,全球自动化内视镜清洗消毒机 (AER) 市场持续稳定成长。根据本报告预测,2024 年全球 AER 市场规模预计将达到 6.977 亿美元,2025 年将达到 7.256 亿美元,到 2032 年将进一步增长至 10.064 亿美元,预测期内复合年增长率 (CAGR) 为 4.8%。 2024 年,北美地区凭藉先进的医疗基础设施和较高的内视镜检查频率,以 49% 的市占率引领全球市场。
自动内视镜清洗消毒机 (AER) 是清洁和消毒可重复使用内视镜的必备设备,它透过自动化的高效消毒循环来实现这一目标。这些系统确保了一致的灭菌效果,最大限度地减少了人为错误,并帮助医疗机构保护患者免受医疗相关感染 (HAI) 的侵害。随着手术量的增加和对感染预防的日益重视,AER 的应用已成为医院安全规程的基本要素。
市场驱动因素
推动市场成长的最大驱动因素之一是内视镜检查数量的增加,而这又受到全球胃肠道、呼吸系统和肿瘤疾病发病率上升的驱动。根据美国国家生物技术资讯中心 (NCBI) 于 2024 年 5 月发布的数据,美国每年将进行超过 1,770 万例胃肠道内视镜检查,凸显了高效再处理设备的巨大需求。全球人口老化也是推动需求成长的因素之一,因为老年人罹患慢性病的比例较高,需要定期进行诊断检测。检查量的激增直接加速了医院和专科诊所对先进自动内视镜清洗消毒系统(AER)的需求。
市场限制因子
儘管成长因素强劲,但低收入国家熟练人员短缺构成了一项重大挑战。内视镜清洗消毒需要专门培训,以确保符合感染控制指南。正如澳洲皇家全科医师学院(RACGP)在2024年6月指出的那样,医疗机构必须确保其员工接受过充分的培训,这在许多资源匮乏的环境中是一项既困难又昂贵的要求。这种技能缺口迫使一些医疗中心依赖人工清洗消毒方法,限制了AER的广泛应用。
市场机会
新兴经济体蕴藏着巨大的成长潜力。人们对医院获得性感染(HAI)的认识不断提高、医院基础设施不断扩建以及对外科和诊断服务的投资增加,都在推动AER的普及。例如,2025年4月,印度Yashoda医院开设了机器人辅助神经外科和神经内视镜手术卓越中心,凸显了该地区微创手术的蓬勃发展。政府主导的现代化项目和不断增长的私营部门投资进一步巩固了对经济高效、结构紧凑且专为小型医疗机构设计的AER系统的长期需求。
市场挑战
AER系统广泛应用的主要障碍之一是其高昂的初始投资。这些成本包括设备本身、专用安装空间、水过滤系统、通风设备以及持续的消毒剂采购。小型诊所和医院往往预算不足,限制了普及。高昂的维护成本和设备维护要求也会推高营运成本,减缓成本敏感地区的市场扩张。
主要市场趋势
技术进步正在推动AER市场的新趋势。由于效率低且人为错误风险高,医疗机构正逐步淘汰人工清洁。这推动了对具备增强型数位化工作流程整合、即时数据记录和追踪系统的自动内视镜清洗系统 (AER) 的需求。例如,Getinge 于 2022 年推出的改良型 ED-Flow AER 就具有增强的数位化连线功能。美国疾病管制与预防中心 (CDC)、美国食品药物管理局 (FDA) 和欧洲胃肠内视镜学会 (ESGE) 的严格指南进一步鼓励医疗机构采用先进的自动化系统,以确保合规性和可追溯性。
北美
北美市场将在 2024 年占领先地位,达到 3.419 亿美元。该地区内视镜检查率高,且感染控制要求严格,这推动了市场需求。在美国,仅胃肠内视镜检查就占所有内视镜检查的 68% 以上。
欧洲
在严格的监管标准、不断增长的医疗保健预算以及向标准化自动化消毒设备的转变的推动下,欧洲将在2024年位居第二。
亚太地区
由于医院感染率上升和医疗设施快速扩张,亚太地区预计将实现最高的复合年增长率。在印度,10-20%的患者会发生医院感染,迫使医院改善其消毒系统。
拉丁美洲、中东和非洲
在这些地区,由于感染控制意识的提高和医疗保健领域的大量投资,自动化消毒设备(AER)的采用率正在逐步提高。
The global automated endoscope reprocessors (AER) market continues to grow steadily as healthcare systems worldwide prioritize stricter infection control, standardized reprocessing procedures, and increased adoption of minimally invasive diagnostics. According to the report, the global AER market was valued at USD 697.7 million in 2024, is projected to reach USD 725.6 million in 2025, and is expected to climb to USD 1,006.4 million by 2032, reflecting a CAGR of 4.8% during the forecast period. In 2024, North America dominated the global market with a 49% share, supported by advanced healthcare infrastructure and high volumes of endoscopic procedures.
Automated endoscope reprocessors are essential devices used to clean and disinfect reusable endoscopes through automated high-level disinfection cycles. These systems ensure consistent sterilization outcomes, minimize human error, and help healthcare facilities protect patients from healthcare-associated infections (HAIs). With rising procedure volume and growing emphasis on infection prevention, AER adoption has become a fundamental part of hospital safety protocols.
Market Drivers
One of the strongest contributors to market growth is the increasing number of endoscopic procedures, driven by rising global incidence of gastrointestinal, pulmonary, and oncological disorders. According to NCBI data published in May 2024, over 17.7 million GI endoscopic procedures are performed annually in the U.S., highlighting the volume of devices that require efficient reprocessing. An aging global population also elevates demand, as older adults experience higher rates of chronic diseases requiring regular diagnostic examinations. This surge in procedures directly accelerates the need for advanced AER systems in hospitals and specialty clinics.
Market Restraints
Despite strong growth factors, a major challenge is the limited availability of skilled staff in low-income countries. Endoscope reprocessing requires specialized training to ensure compliance with infection control guidelines. As highlighted by the Royal Australian College of General Practitioners (RACGP) in June 2024, facilities must ensure staff are adequately trained-a requirement that is difficult and costly for many under-resourced settings. This skill gap leads some healthcare centers to rely on manual reprocessing methods, limiting AER penetration.
Market Opportunities
Emerging economies present substantial growth prospects. Rising awareness of HAIs, expanding hospital infrastructure, and increased investments in surgical and diagnostic services are boosting adoption. For example, in April 2025, Yashoda Hospitals in India launched a Center of Excellence for Robotic Neurosurgery and Neuro Endoscopy, highlighting the region's expansion in minimally invasive procedures. Government-funded modernization programs and increasing private sector investments further strengthen the long-term demand for cost-effective, compact AER systems designed for smaller facilities.
Market Challenges
One of the key barriers to broader adoption is the high initial investment associated with AER systems. Costs include the equipment itself, dedicated installation space, water filtration systems, ventilation, and ongoing purchases of disinfectants. Smaller clinics and hospitals often lack sufficient budgets, restricting their adoption. Higher maintenance costs and device servicing needs also elevate operational expenses, slowing market expansion in cost-sensitive regions.
Key Market Trends
Technological advancements are shaping new trends in the AER market. Healthcare providers are transitioning away from manual cleaning due to its inefficiency and higher risk of human error. AERs equipped with enhanced digital workflow integration, real-time data logging, and tracking systems are in growing demand. For example, Getinge's updated ED-Flow AER introduced in 2022 incorporated improved digital connectivity features. Strict guidelines from CDC, FDA, and ESGE are further encouraging facilities to adopt advanced, automated systems to ensure compliance and traceability.
North America
North America led the market in 2024 with USD 341.9 million. High endoscopy procedure rates and advanced infection control requirements drive regional demand. GI procedures alone account for over 68% of all endoscopic procedures in the U.S.
Europe
Europe ranked second in 2024, supported by strong regulatory standards, increasing healthcare budgets, and a shift toward standardized automated reprocessing.
Asia Pacific
Asia Pacific is expected to record the highest CAGR, fueled by rising nosocomial infection rates and rapid healthcare facility expansion. In India, 10-20% of patients experience hospital-acquired infections, pushing hospitals toward improved disinfection systems.
Latin America & Middle East & Africa
These regions are gradually adopting AERs, supported by increasing awareness of infection control and targeted healthcare investments.
Conclusion
Growing from USD 697.7 million in 2024 to USD 725.6 million in 2025, and projected to reach USD 1,006.4 million by 2032, the global automated endoscope reprocessors market is on a steady upward trajectory. Rising endoscopy volumes, strict infection control mandates, and expanding healthcare capacity in emerging economies will continue shaping market growth in the coming years.
Segmentation By Type
By Loading Type
By Portability
By Type of Endoscope Reprocessed
By End-user
By Region